David Protein CEO says ‘diet trends are over’ because of GLP-1s: ‘What’s next is really hard to predict’

David Protein CEO Peter Rahal claims GLP-1 receptor agonists are ending traditional diet trends, citing their impact on appetite regulation and weight loss. Food companies like Nestle and Conagra are adapting by creating products for GLP-1 users, while David Protein capitalizes on 'proteinmaxxing' to meet demand for high-protein snacks. The rise of GLP-1 medications has disrupted weight loss programs, contributing to WeightWatchers' bankruptcy and a shift in food industry priorities.